There is a picture the industry does very little to correct: a founder with a problem, a laboratory, and a formula that emerged from their own frustration. It is a good story and it is occasionally true. Far more often the sequence runs the other way round. A brief is written, a contract manufacturer is approached, and a chemist who will never be named designs a product to fit a price, a pack and a set of claims that were agreed before any ingredient was chosen.
The brief comes first, not the formula
Cosmetic development almost always begins with a document rather than an idea about chemistry. A development brief typically fixes several things at once: what the product is meant to be sold as, what it must cost to make, what it must feel like, what claims marketing intends to run, what pack it has to fit, and when it must be ready. Those constraints are not negotiable in the way a scientist might hope. The launch date is usually tied to a retailer's range review or a seasonal window, and the cost is tied to a retail price someone has already decided on.
A formulator reading that brief is not being asked what would work best. They are being asked what is the best product that can exist inside those constraints. That is a genuine craft and good formulators are very good at it. It is also a different question from the one shoppers assume was asked.
The three arrangements, and how they differ
Almost every product on a British shelf came out of one of three structures. The differences matter, because they determine who holds the knowledge and who can change the product later.
| Arrangement | Who designs the formula | What the brand usually holds |
|---|---|---|
| In-house laboratory | Chemists employed by the brand, often with pilot equipment on site | The formula, the test data, the supplier relationships and the ability to reformulate at will |
| Contract manufacturer development | Chemists employed by the manufacturer, working to the brand's brief | The brief, the pack, the branding and a commercial agreement over the resulting formula |
| Independent consultant | A freelance cosmetic chemist, with manufacture placed separately | Usually the formula itself, and the freedom to move it to another factory |
The third route is the one most often missed in coverage of the sector. An independent formulator can design a product and hand the brand a document it owns outright, which is then taken to a factory for manufacture only. It costs more up front and it buys independence later. The second route costs less up front and frequently ties the brand to one factory for the life of the product.
Who owns the formula
This is the question that decides whether a brand is a business or a marketing arrangement. Ownership of a cosmetic formula is a contractual matter, not a regulatory one. There is no register you can search. A development agreement will state whether the formula is assigned to the brand, licensed to it, or retained entirely by the manufacturer with the brand holding nothing but the right to buy finished units.
The consequence is practical. A brand that does not own its formula cannot move production without redeveloping the product, cannot always obtain the full quantitative composition, and is dependent on one factory's capacity, pricing and priorities. When you see a product quietly change texture or performance after a few years, a change of manufacturing partner is one of the ordinary explanations.
Selling development at cost, or below it
A contract manufacturer that develops a formula cheaply is not being generous. Development is the mechanism by which a customer becomes difficult to lose. Once a brand's best selling product exists only inside one factory's documentation, price rises are easier to pass on and competing quotes are harder to act on.
The money is not made on the development. It is made on the units, for years.
- The contract manufacturer. Locks in repeat volume and reduces the risk of losing the account to a rival factory
- The brand owner. Gets to market faster and with less capital than an in-house laboratory would need
- The raw material supplier. Sells through a factory that already specifies its ingredients as standard
- The shopper. Gets a competently made product, and no visibility of any of the above
This is a structural description of how development is commonly financed in the sector. It is not a claim about the conduct of any particular company.
What a cosmetic chemist actually does all day
Very little of the job is invention. Most of it is constraint management. A formulator has to make an emulsion that stays together for years, resists microbial growth, survives being shipped in a hot lorry and a cold warehouse, is compatible with the specific plastic of the chosen pack, meets the restrictions set out in the annexes to the cosmetics regulation, can be made at scale on the equipment available, and feels the way the brief demanded.
Those requirements fight each other constantly. Raising the level of an active can destabilise the emulsion. Changing the emulsifier changes the skin feel. A preservative that works at one pH stops working at another. Every bench iteration is a negotiation, and the version that reaches you is the one that survived every constraint at once, not the one that performed best on any single measure.
Platform formulas and where they come from
Raw material suppliers publish starting formulations to demonstrate their ingredients. These are freely available technical documents, written to show a material at its best in a plausible product. They are a legitimate and completely normal starting point, and a large amount of what is on sale began life as one, adapted for cost, feel, stability and claims.
None of this is a scandal. It is how most manufacturing industries work. It becomes misleading only when a brand implies a level of proprietary science that never occurred, and that implication is usually made through tone rather than through any specific statement that could be challenged.
Developed by our team of scientists
That people with scientific qualifications were involved somewhere in the development of the product. That is a very wide net. It can cover an in-house laboratory, and it can equally cover a brand employee with a science degree who signed off work done at a contract manufacturer.
There is no defined meaning of scientist and no register of who may be described as one in advertising.
It does not mean the brand employs formulators. It does not mean the brand owns the formula. It does not mean the work was original rather than adapted from a supplier's starting formulation. It does not tell you whether anyone with a relevant qualification made a single decision about the composition.
The brand would have to say who those scientists are, who employs them, and what they decided. A specific and checkable version of this claim would name the discipline and the role: a formulation chemist employed by the brand who designed the composition, for example. Brands that can say that usually do, because it is a real point of difference.
Can you tell from the outside
Usually not, and it is worth being clear about that rather than pretending there is a trick. The label gives you the responsible person, which is the legal point of contact inside Great Britain or Northern Ireland, and that is frequently the brand itself even when the brand has never made anything. It gives you an ingredient list. It does not give you the manufacturer, the developer, or whether the formula is exclusive.
There are weak signals. A brand that discusses its formulation decisions in specific technical terms, names the trade-offs it accepted, and explains why it chose one emulsifier system over another is more likely to have people who understand the formula. A brand whose technical language is entirely in the register of marketing is not necessarily hiding anything, but it is telling you nothing either.
The practical response is not to become a detective. It is to stop treating the origin story as evidence. What the product does for your skin is testable by you over weeks. Who wrote the formula is not, and it matters far less than the industry's own storytelling implies. If you want to look further at what the pack does tell you, start with what INCI ordering does and does not tell you, and with what a brand owns and what a contract manufacturer owns.
Why the industry keeps this quiet
There is no conspiracy, only a set of ordinary commercial reasons that point the same way. Manufacturers usually sign confidentiality agreements and cannot name their customers. Brands prefer a story about a founder to a story about a factory in another county. Retailers buy narratives as well as products. Journalists are given access to the narrative and rarely to the plant.
The result is a sector where the least visible participants do most of the technical work. Naming that is not an attack on anybody. Contract manufacturing is a skilled, heavily regulated business, and the chemists inside it are frequently better than the marketing that sits on top of their work. The point of saying so is simply that you should buy the product rather than the biography.